A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins significantly associated with incident ischemic stroke risk, of which 26 are novel. Twenty-six of these associations were replicated in two independent cohorts. Mendelian randomization analyses suggested that MMP12 (matrix metallopeptidase-12) may have a direct protective effect on ischemic stroke risk, while CNTN1 (contactin-1) may have a direct harmful effect. The study profiled 4,954 blood proteins using aptamers in 14,139 participants without prevalent stroke at baseline, with median follow-up of 25 years in ARIC and 12 years in CHS, during which 1,397 participants (10%) experienced an ischemic stroke; study-specific Cox regression models adjusted for ischemic stroke risk factors were combined via fixed-effects meta-analysis and validated in the AGES-Reykjavik and UK Biobank cohorts, where 37 of 44 associations (84%) were directionally concordant and 26 (59%) met replication criteria. These findings highlight novel risk biomarkers and two potential etiologic factors regulated in response to atherosclerosis and obesity, which may inform the development of new preventive therapies for ischemic stroke. Source: https://www.ahajournals.org/
In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…
People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
This website uses cookies.